{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:47:17Z","timestamp":1770500837307,"version":"3.49.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1053\/j.seminoncol.2004.09.038","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:58:14Z","timestamp":1131026294000},"page":"24-34","source":"Crossref","is-referenced-by-count":45,"title":["Colorectal cancer prevention: Is an ounce of prevention worth a pound of cure?"],"prefix":"10.1053","volume":"32","author":[{"given":"Sharlene","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank A.","family":"Sinicrope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2004.09.038_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Tiwari","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib2","series-title":"National Cancer Institute of Canada, Canadian Cancer Statistics","year":"2003"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"Vogelstein","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.8484122","article-title":"Microsatellite instability in cancer of the proximal colon","volume":"260","author":"Thibodeau","year":"1993","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM200001133420201","article-title":"Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer","volume":"342","author":"Gryfe","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0165-4608(96)00290-7","article-title":"An update of HNPCC (Lynch syndrome)","volume":"93","author":"Lynch","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJM199805213382101","article-title":"Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease","volume":"338","author":"Aaltonen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/gut.23.10.835","article-title":"Polyps and cancer of the large bowel","volume":"23","author":"Williams","year":"1982","journal-title":"Gut"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJM199312303292701","article-title":"Prevention of colorectal cancer by colonoscopic polypectomy","volume":"329","author":"Winawer","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0889-8553(02)00055-9","article-title":"Chemoprevention of colorectal cancer","volume":"31","author":"Viner","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib11","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM198506133122403","article-title":"Dominant inheritance of adenomatous colonic polyps and colorectal cancer","volume":"312","author":"Burt","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0002-9610(89)90442-X","article-title":"Sulindac for polyposis of the colon","volume":"157","author":"Waddell","year":"1989","journal-title":"Am J Surg"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","article-title":"Aspirin use and reduced risk of fatal colon cancer","volume":"325","author":"Thun","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-121-4-199408150-00001","article-title":"Aspirin use and the risk for colorectal cancer and adenoma in male health professionals","volume":"121","author":"Giovannucci","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","article-title":"Aspirin and the risk of colorectal cancer in women","volume":"333","author":"Giovannucci","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-128-9-199805010-00003","article-title":"Aspirin use and colorectal cancer","volume":"128","author":"Sturmer","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.159.2.161","article-title":"Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer","volume":"159","author":"Smalley","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-140-3-200402030-00006","article-title":"A prospective study of aspirin use and the risk for colorectal adenoma","volume":"140","author":"Chan","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/bies.950171207","article-title":"Inflammation, reproduction, cancer and all that\u2026. The regulation and role of the inducible prostaglandin synthase","volume":"17","author":"Herschman","year":"1995","journal-title":"Bioessays"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/gast.1999.0029900350","article-title":"Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers","volume":"117","author":"Sinicrope","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","article-title":"Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)","volume":"87","author":"Oshima","year":"1996","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib24","first-page":"409","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis","volume":"58","author":"Kawamori","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib25","first-page":"710","article-title":"Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam","volume":"56","author":"Jacoby","year":"1996","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/carcin\/19.1.87","article-title":"The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis","volume":"19","author":"Mahmoud","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib27","first-page":"1733","article-title":"Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor","volume":"61","author":"Oshima","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib28","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0016-5085(98)70330-0","article-title":"Aspirin, NSAIDS, and colon cancer prevention","volume":"114","author":"Gupta","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib29","first-page":"6323","article-title":"Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells","volume":"62","author":"Sun","year":"2002","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib30","first-page":"1811","article-title":"Inhibition of apoptosis during development of colorectal cancer","volume":"55","author":"Bedi","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0014-5793(02)03535-4","article-title":"Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells","volume":"531","author":"Yamazaki","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib32","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.01-0299fje","article-title":"COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib","volume":"15","author":"Grosch","year":"2001","journal-title":"FASEB J"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI118060","article-title":"Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells","volume":"96","author":"Shiff","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib34","first-page":"3110","article-title":"Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis","volume":"55","author":"Piazza","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib35","first-page":"4903","article-title":"Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells","volume":"62","author":"Tang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib36","first-page":"6918","article-title":"Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells","volume":"61","author":"Huang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.290.5493.989","article-title":"Role of BAX in the apoptotic response to anticancer agents","volume":"290","author":"Zhang","year":"2000","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib38","first-page":"1679","article-title":"Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug","volume":"3","author":"Elder","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib39","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0016-5085(97)70007-6","article-title":"A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells","volume":"113","author":"Sheng","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib40","first-page":"1301","article-title":"Modulation of apoptosis by sulindac, curcumin, phenylethyl-3- methylcaffeate, and 6-phenylhexyl isothiocyanate","volume":"57","author":"Samaha","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib41","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1073\/pnas.93.15.7950","article-title":"Apoptosis and APC in colorectal tumorigenesis","volume":"93","author":"Morin","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib42","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/gut.45.6.822","article-title":"Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac","volume":"45","author":"Keller","year":"1999","journal-title":"Gut"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib43","first-page":"670","article-title":"Rectal epithelial apoptosis does not predict response to sulindac treatment or polyp development in presymptomatic familial adenomatous polyposis patients","volume":"11","author":"Keller","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib44","first-page":"1","article-title":"Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis (FAP) patients","volume":"3","author":"Sinicrope","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib45","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1073\/pnas.94.7.3336","article-title":"Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential","volume":"94","author":"Tsujii","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib46","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-2952(96)00181-5","article-title":"Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway","volume":"52","author":"Hanif","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib49","first-page":"4356","article-title":"Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines","volume":"59","author":"Molina","year":"1999","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib50","first-page":"2909","article-title":"Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels","volume":"57","author":"Piazza","year":"1997","journal-title":"Cancer Res"},{"issue":"suppl","key":"10.1053\/j.seminoncol.2004.09.038_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jcb.240590804","article-title":"Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?","volume":"22","author":"Alberts","year":"1995","journal-title":"J Cell Biochem"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib52","first-page":"6045","article-title":"Celecoxib prevents tumor growth in vivo without toxicity to normal gut","volume":"60","author":"Williams","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib53","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib54","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs","volume":"272","author":"Lehmann","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-8674(00)81664-5","article-title":"PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs","volume":"99","author":"He","year":"1999","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib56","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","article-title":"Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis","volume":"328","author":"Giardiello","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib57","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib58","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMoa012015","article-title":"Primary chemoprevention of familial adenomatous polyposis with sulindac","volume":"346","author":"Giardiello","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib59","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"Sandler","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib60","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib61","first-page":"275","article-title":"A dose-finding study of aspirin for chemoprevention utilizing rectal mucosal prostaglandin E(2) levels as a biomarker","volume":"11","author":"Sample","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0016-5085(03)00887-4","article-title":"Daily soluble aspirin and prevention of colorectal adenoma recurrence","volume":"125","author":"Benamouzig","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib63","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7326\/0003-4819-135-9-200111060-00007","article-title":"Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis","volume":"135","author":"Ladabaum","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib64","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/gast.2002.29689","article-title":"Chemoprevention of colorectal cancer by aspirin","volume":"122","author":"Suleiman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","article-title":"Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the U.S. Preventive Services Task Force","volume":"136","author":"Hayden","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib66","first-page":"1876","article-title":"Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo","volume":"27","author":"Bensen","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib67","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti- inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib68","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1572-0241.2000.02194.x","article-title":"Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor","volume":"95","author":"Goldstein","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib69","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","article-title":"Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis","volume":"347","author":"Chan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib70","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(02)11131-7","article-title":"COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease","volume":"360","author":"Ray","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib71","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1021\/jm00212a012","article-title":"Inhibitors of polyamine biosynthesis. 4. Effects of alpha-methyl-(+\/\u2212)-ornithine and methylglyoxal bis(guanylhydrazone) on growth and polyamine content of L1210 leukemic cells of mice","volume":"20","author":"Newton","year":"1977","journal-title":"J Med Chem"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib73","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1016\/S0021-9258(17)39505-4","article-title":"Amplification of ornithine decarboxylase gene in response to polyamine deprivation in Chinese hamster ovary cells","volume":"260","author":"Pohjanpelto","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib74","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM198407123110202","article-title":"Ornithine decarboxylase as a biologic marker in familial colonic polyposis","volume":"311","author":"Luk","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib75","first-page":"3226","article-title":"Ornithine decarboxylase activity in the rat and human colon","volume":"44","author":"Rozhin","year":"1984","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib76","first-page":"369","article-title":"Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa","volume":"2","author":"Hixson","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib77","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1073\/pnas.90.16.7804","article-title":"The ornithine decarboxylase gene is a transcriptional target of c-Myc","volume":"90","author":"Bello-Fernandez","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib78","first-page":"1769","article-title":"Low-level c-myc amplification in human colonic carcinoma cell lines and tumors","volume":"57","author":"Augenlicht","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib79","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway","volume":"281","author":"He","year":"1998","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib80","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/carcin\/20.9.1709","article-title":"APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse","volume":"20","author":"Erdman","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib81","first-page":"945","article-title":"Development of difluoromethylornithine (DFMO) as a chemoprevention agent","volume":"5","author":"Meyskens","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib82","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/(SICI)1097-4644(19961101)63:2<252::AID-JCB12>3.0.CO;2-L","article-title":"Mucosal polyamine measurements and colorectal cancer risk","volume":"63","author":"Wang","year":"1996","journal-title":"J Cell Biochem"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib83","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/90.16.1212","article-title":"Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention","volume":"90","author":"Meyskens","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib84","first-page":"1864","article-title":"Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos","volume":"60","author":"Jacoby","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib85","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/carcin\/20.3.425","article-title":"Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon","volume":"20","author":"Li","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib86","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1073\/pnas.1332465100","article-title":"Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene","volume":"100","author":"Martinez","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib87","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000198579","article-title":"Acute and chronic effect of dietary cholic acid on colonic epithelial cell proliferation","volume":"21","author":"Deschner","year":"1981","journal-title":"Digestion"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3835(97)00452-7","article-title":"Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats","volume":"124","author":"Hori","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib89","first-page":"573","article-title":"Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats","volume":"64","author":"Cohen","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib90","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0304-3835(88)90023-7","article-title":"Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer","volume":"38","author":"Stadler","year":"1988","journal-title":"Cancer Lett"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib91","first-page":"259","article-title":"Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats","volume":"18","author":"Narisawa","year":"1999","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib92","first-page":"5071","article-title":"Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid","volume":"54","author":"Earnest","year":"1994","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib93","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib94","first-page":"91","article-title":"Proving the bile acid hypothesis for colon carcinogenesis","volume":"22","author":"Alberts","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib95","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/archinte.156.18.2085","article-title":"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study","volume":"156","author":"Pedersen","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib96","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib97","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/carcin\/15.9.2045","article-title":"Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice","volume":"15","author":"Narisawa","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib98","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0016-5085(99)70342-2","article-title":"Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac","volume":"117","author":"Agarwal","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib99","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jnci\/87.7.517","article-title":"Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women","volume":"87","author":"Calle","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib100","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-128-9-199805010-00001","article-title":"Postmenopausal hormone use and risk for colorectal cancer and adenoma","volume":"128","author":"Grodstein","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib101","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09513599309152509","article-title":"Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels","volume":"7","author":"Campagnoli","year":"1993","journal-title":"Gynecol Endocrinol"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib102","first-page":"1201","article-title":"Reproduction, endogenous and exogenous sex hormones, and colon cancer","volume":"65","author":"McMichael","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib104","first-page":"291","article-title":"Dietary and supplemental calcium and the recurrence of colorectal adenomas","volume":"7","author":"Hyman","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib105","first-page":"163","article-title":"Calcium, vitamin D, and colorectal cancer","volume":"7","author":"Martinez","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib106","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM199901143400204","article-title":"Calcium supplements for the prevention of colorectal adenomas","volume":"340","author":"Baron","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib107","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/jnci\/djg110","article-title":"Vitamin D, calcium supplementation, and colorectal adenomas","volume":"95","author":"Grau","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib108","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrc1144","article-title":"Chemoprevention of colon cancer by calcium, vitamin D and folate","volume":"3","author":"Lamprecht","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib109","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-129-7-199810010-00002","article-title":"Multivitamin use, folate, and colon cancer in women in the Nurses\u2019 Health Study","volume":"129","author":"Giovannucci","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib110","first-page":"227","article-title":"The influence of folate and multivitamin use on the familial risk of colon cancer in women","volume":"11","author":"Fuchs","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jnci\/90.1.57","article-title":"Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas","volume":"90","author":"Baron","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib112","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200004203421602","article-title":"Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians\u2019 Network","volume":"342","author":"Alberts","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib113","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ajcn\/79.4.691","article-title":"Folate and colorectal neoplasia","volume":"79","author":"Martinez","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib114","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/030089160008600201","article-title":"The epidemiology of selenium and human cancer","volume":"86","author":"Vinceti","year":"2000","journal-title":"Tumori"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/taap.1999.8623","article-title":"Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2\u2032-dimethyl-4-aminobiphenyl","volume":"157","author":"Feng","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib116","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/carcin\/21.4.617","article-title":"Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4-phenylene bis(methylene)selenocyanate","volume":"21","author":"Rao","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib117","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1001\/jama.276.24.1957","article-title":"Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial","volume":"276","author":"Clark","year":"1996","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib118","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.2001.tb02730.x","article-title":"The future of colon cancer prevention","volume":"952","author":"Umar","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib119","first-page":"1179","article-title":"Expression of putative anticancer targets in familial adenomatous polyposis and its association with the APC mutation status","volume":"19","author":"Humar","year":"2001","journal-title":"Int J Oncol"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib120","first-page":"135","article-title":"Aberrant crypt foci in human colon carcinogenesis","volume":"21","author":"Dolara","year":"1997","journal-title":"Cancer Detect Prev"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib121","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/carcin\/15.5.1049","article-title":"Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents","volume":"15","author":"Pereira","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminoncol.2004.09.038_bib122","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM199810293391803","article-title":"Aberrant crypt foci of the colon as precursors of adenoma and cancer","volume":"339","author":"Takayama","year":"1998","journal-title":"N Engl J Med"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775404004671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775404004671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T03:52:03Z","timestamp":1626666723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775404004671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0093775404004671"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2004.09.038","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}